TCI GENE Inc. (6879.TWO)
TWD 46.85
(4.11%)
TWD 46.85
(4.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 10.04 Million TWD | -89.02% |
| 2022 | 91.51 Million TWD | -22.17% |
| 2021 | 117.58 Million TWD | 145.17% |
| 2020 | 47.96 Million TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 2.83 Million TWD | 0.0% |
| 2024 Q1 | 2.83 Million TWD | 35.31% |
| 2023 Q2 | 869.5 Thousand TWD | 0.0% |
| 2023 FY | 10.04 Million TWD | -89.02% |
| 2023 Q1 | 869.5 Thousand TWD | -77.04% |
| 2023 Q4 | 2.09 Million TWD | 0.0% |
| 2023 Q3 | 2.09 Million TWD | 141.0% |
| 2022 Q4 | 3.78 Million TWD | 0.0% |
| 2022 FY | 91.51 Million TWD | -22.17% |
| 2022 Q3 | 3.78 Million TWD | 0.0% |
| 2021 FY | 117.58 Million TWD | 145.17% |
| 2020 FY | 47.96 Million TWD | 0.0% |
| 2019 FY | - TWD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 281.85 Million TWD | 96.435% |
| Level Biotechnology Inc. | 67.55 Million TWD | 85.124% |
| Sagittarius Life Science Corp | -64.37 Million TWD | 115.61% |
| NeoCore Technology Co., Ltd. | -84.94 Million TWD | 111.83% |
| GeneReach Biotechnology Corp. | -229.28 Million TWD | 104.383% |
| Genomics BioSci & Tech. Co.,Ltd. | -84.99 Million TWD | 111.823% |
| Visgeneer Inc. | -21.15 Million TWD | 147.493% |
| Sunmax Biotechnology Co., Ltd. | 894.79 Million TWD | 98.877% |
| G&E Herbal Biotechnology Co., Ltd. | 80.68 Million TWD | 87.545% |
| Neith Corporation | -48.85 Million TWD | 120.569% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -6.61 Million TWD | 252.027% |
| Enimmune corporation | -243.47 Million TWD | 104.127% |
| TaiRx, Inc. | -214.69 Million TWD | 104.681% |
| EirGenix Inc. | -1.03 Billion TWD | 100.974% |
| BioLASCO Taiwan Co., Ltd. | 63.33 Million TWD | 84.134% |
| Sunny Pharmtech Inc. | -72.09 Million TWD | 113.938% |
| Advagene Biopharma Co., Ltd. | -93.33 Million TWD | 110.766% |
| BioGend Therapeutics Co., Ltd. | -176.54 Million TWD | 105.692% |
| Feng Chi Biotech Corp. | 24.16 Million TWD | 58.41% |
| Lukas Biomedical Inc. | -43.56 Million TWD | 123.069% |
| RBC Bioscience Corporation | 14.53 Million TWD | 30.882% |
| BiOptic Inc. | 44.05 Million TWD | 77.189% |
| Anti-Microbial Savior BioteQ Co., Ltd | -56.74 Million TWD | 117.708% |
| Shine-On BioMedical Co.,Ltd. | -62.68 Million TWD | 116.031% |
| Great Novel Therapeutics Biotech & Medicals | -65.81 Million TWD | 115.267% |
| Syngen Biotech Co.,Ltd. | 334.08 Million TWD | 96.992% |
| Mycenax Biotech Inc. | -602.1 Million TWD | 101.669% |
| Medigen Vaccine Biologics Corporation | -1.21 Billion TWD | 100.828% |
| Bio Preventive Medicine Corp. | -70.58 Million TWD | 114.237% |
| TaiMed Biologics Inc. | -166.23 Million TWD | 106.045% |
| GlycoNex Incorporation | -259.86 Million TWD | 103.867% |
| Taiwan Advance Bio-Pharmaceutical Inc. | -2.25 Million TWD | 546.028% |
| SynCore Biotechnology Co.,Ltd | -45.5 Million TWD | 122.085% |
| Lin BioScience, Inc. | -1.09 Billion TWD | 100.916% |
| BRIM Biotechnology, Inc. | -694.12 Million TWD | 101.448% |
| VBI | -16.13 Million TWD | 162.292% |
| CHO Pharma, Inc. | -268.99 Million TWD | 103.736% |
| NaviFUS Corp. | -76.42 Million TWD | 113.149% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -93.95 Million TWD | 110.696% |
| Sinew Pharma Inc. | -186.25 Million TWD | 105.395% |
| Andros Pharmaceuticals Co.,Ltd | -67.69 Million TWD | 114.844% |
| Greenyn Biotechnology Co., Ltd | 159.81 Million TWD | 93.712% |
| Lumosa Therapeutics Co., Ltd. | -375.62 Million TWD | 102.675% |
| AP Biosciences Inc | -347.47 Million TWD | 102.892% |
| Medigen Biotechnology Corp. | -1.23 Billion TWD | 100.815% |
| 3D Global Biotech Inc. | -62.85 Million TWD | 115.988% |
| Pharmosa Biopharm Inc. | -2.82 Million TWD | 455.843% |
| Intech Biopharm Corporation | -304.39 Million TWD | 103.301% |
| Oneness Biotech Co., Ltd. | -1.09 Billion TWD | 100.916% |
| Eusol Biotech Co.,Ltd. | -41.48 Million TWD | 124.225% |
| TWi Biotechnology, Inc. | -169.55 Million TWD | 105.927% |
| Ever Supreme Bio Technology Co., Ltd | 337.73 Million TWD | 97.025% |
| MegaPro Biomedical Co., Ltd | -127.25 Million TWD | 107.897% |
| Senhwa Biosciences, Inc. | -311.11 Million TWD | 103.23% |
| Taiwan Bio Therapeutics Co., Ltd | -212.2 Million TWD | 104.736% |
| NatureWise Biotech & Medicals Corporation | 3.43 Million TWD | -192.632% |
| PharmaEngine, Inc. | 277.18 Million TWD | 96.375% |
| Savior Lifetec Corporation | -2.42 Million TWD | 515.248% |
| TaiGen Biopharmaceuticals Holdings Limited | -174.69 Million TWD | 105.752% |
| OBI Pharma, Inc. | -2.08 Billion TWD | 100.481% |
| Meribank Biotech Co., Ltd | -123.15 Million TWD | 108.16% |
| Acepodia, Inc. | -435.97 Million TWD | 102.305% |
| Caliway Biopharmaceuticals Co., Ltd. | -487.95 Million TWD | 102.059% |